Thank you for that. That's great.
Mr. Arbuckle, I have a question for you, if I still have time.
Following up on my colleague Mr. Sorbara's comments, which I thought were quite good, in terms of the reasonableness component on anonymized data that you were talking about, what I want to understand better is what's at stake. I wonder if you could provide an example where the health outcomes would actually be potentially compromised.
I think what you implied to me was that if you were adding that reasonableness component to the clauses around anonymized data in the bill, you would in fact allow for that contextualization and perhaps a strong protected environment, in which case you could use that data for purposes that are beneficial. You spoke to health outcomes. Could you give us an example to illustrate?